Related Experiment Video
Updated: Jun 4, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Metronidazole-induced encephalopathy in a patient with infectious colitis: a case report
Hoon Kim1, Young Woo Kim, Seoung Rim Kim
1Department of Neurosurgery, Bucheon St Mary's Hospital, College of Medicine, Catholic University, Bucheon, Korea. jkw94@naver.com.
Introduction:
Encephalopathy is a rare disease caused by adverse effects of antibiotic drugs such as metronidazole. The incidence of metronidazole-induced encephalopathy is unknown, although several previous studies have addressed metronidazole neurotoxicity. Here, we report the case of a patient with reversible cerebellar dysfunction on magnetic resonance imaging, induced by prolonged administration of metronidazole for the treatment of infectious colitis.
Case Presentation:
A 71-year-old Asian man, admitted to our hospital with hematochezia, underwent Hartmann's operation for the treatment of colorectal cancer three years ago. He was diagnosed with an infectious colitis by colonoscopy. After taking metronidazole, he showed drowsiness and slow response to verbal commands. Brain magnetic resonance imaging showed obvious bilateral symmetric hyperintensities within his dentate nucleus, tectal region of the cerebellum, and splenium of corpus callosum in T2-weighted images and fluid attenuated inversion recovery images. Our patient's clinical presentation and magnetic resonance images were thought to be most consistent with metronidazole toxicity. Therefore, we discontinued metronidazole, and his cerebellar syndrome resolved. Follow-up magnetic resonance imaging examinations showed complete resolution of previously noted signal changes.
Conclusion:
Metronidazole may produce neurologic side effects such as cerebellar syndrome, and encephalopathy in rare cases. We show that metronidazole-induced encephalopathy can be reversed after cessation of the drug. Consequently, careful consideration should be given to patients presenting with complaints of neurologic disorder after the initiation of metronidazole therapy.
Insights
Metronidazole can cause rare neurological side effects like encephalopathy and cerebellar syndrome. This case shows these effects are reversible after stopping the antibiotic, highlighting the need for careful monitoring.
Area of Science:
- Neurology
- Pharmacology
- Radiology
Background:
- Encephalopathy is a rare adverse effect of antibiotics like metronidazole.
- Metronidazole neurotoxicity has been previously studied, but incidence is unknown.
- This report details a case of reversible cerebellar dysfunction linked to metronidazole.
Purpose of the Study:
- To report a case of metronidazole-induced encephalopathy.
- To highlight the reversibility of metronidazole-induced neurological symptoms.
- To emphasize the importance of considering metronidazole toxicity in patients with neurological disorders.
Main Methods:
- Case presentation of a 71-year-old man with infectious colitis treated with metronidazole.
- Clinical observation of drowsiness and slow response after metronidazole administration.
- Brain MRI (T2-weighted and FLAIR) to assess neurological changes.
Main Results:
- Patient developed drowsiness and slow response after metronidazole treatment.
- MRI revealed bilateral symmetric hyperintensities in the dentate nucleus, cerebellum, and corpus callosum.
- Discontinuation of metronidazole led to resolution of cerebellar syndrome and MRI signal changes.
Conclusions:
- Metronidazole can cause neurological side effects, including cerebellar syndrome and encephalopathy.
- Metronidazole-induced encephalopathy is reversible upon drug cessation.
- Clinicians should consider metronidazole toxicity in patients with new-onset neurological symptoms.
Related Concept Videos
Hepatic Encephalopathy
Amebiasis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
